Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05553639
Title HB-302/HB-301 Therapy in Participants With Metastatic Castration-Resistant Prostate Cancer
Recruitment Terminated
Gender male
Phase Phase Ib/II
Variant Requirements No
Sponsors Hookipa Biotech GmbH
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope Duarte California 91010 United States Details
California Cancer Associates for Research & Excellence (cCARE) San Marcos California 92069 United States Details
University of Miami - Sylvester Comprehensive Cancer Center Miami Florida 33136 United States Details
Miami Cancer Institute Miami Florida 33176 United States Details
Emory University Hospital Atlanta Georgia 30322 United States Details
The Cancer Institute of New Jersey CINJ Rutgers New Brunswick New Jersey 08901 United States Details
Columbia University Irving Medical Center New York New York 10032 United States Details
Memorial Sloan-Kettering Cancer Center New York New York 10065 United States Details
Providence Cancer Institute Portland Oregon 97213 United States Details
Thompson Cancer Survival Center Knoxville Tennessee 37916 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field